Cargando…
Best serum biomarker combination for ovarian cancer classification
BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219009/ https://www.ncbi.nlm.nih.gov/pubmed/30396341 http://dx.doi.org/10.1186/s12938-018-0581-6 |
_version_ | 1783368564241072128 |
---|---|
author | Song, Hye-Jeong Yang, Eun-Suk Kim, Jong-Dae Park, Chan-Young Kyung, Min-Sun Kim, Yu-Seop |
author_facet | Song, Hye-Jeong Yang, Eun-Suk Kim, Jong-Dae Park, Chan-Young Kyung, Min-Sun Kim, Yu-Seop |
author_sort | Song, Hye-Jeong |
collection | PubMed |
description | BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression. RESULTS: The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer. CONCLUSIONS: We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important. |
format | Online Article Text |
id | pubmed-6219009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62190092018-11-08 Best serum biomarker combination for ovarian cancer classification Song, Hye-Jeong Yang, Eun-Suk Kim, Jong-Dae Park, Chan-Young Kyung, Min-Sun Kim, Yu-Seop Biomed Eng Online Research BACKGROUND: Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. METHODS: In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression. RESULTS: The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer. CONCLUSIONS: We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important. BioMed Central 2018-11-06 /pmc/articles/PMC6219009/ /pubmed/30396341 http://dx.doi.org/10.1186/s12938-018-0581-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Song, Hye-Jeong Yang, Eun-Suk Kim, Jong-Dae Park, Chan-Young Kyung, Min-Sun Kim, Yu-Seop Best serum biomarker combination for ovarian cancer classification |
title | Best serum biomarker combination for ovarian cancer classification |
title_full | Best serum biomarker combination for ovarian cancer classification |
title_fullStr | Best serum biomarker combination for ovarian cancer classification |
title_full_unstemmed | Best serum biomarker combination for ovarian cancer classification |
title_short | Best serum biomarker combination for ovarian cancer classification |
title_sort | best serum biomarker combination for ovarian cancer classification |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219009/ https://www.ncbi.nlm.nih.gov/pubmed/30396341 http://dx.doi.org/10.1186/s12938-018-0581-6 |
work_keys_str_mv | AT songhyejeong bestserumbiomarkercombinationforovariancancerclassification AT yangeunsuk bestserumbiomarkercombinationforovariancancerclassification AT kimjongdae bestserumbiomarkercombinationforovariancancerclassification AT parkchanyoung bestserumbiomarkercombinationforovariancancerclassification AT kyungminsun bestserumbiomarkercombinationforovariancancerclassification AT kimyuseop bestserumbiomarkercombinationforovariancancerclassification |